ID: ALA4559205

Max Phase: Preclinical

Molecular Formula: C19H14Cl2N2O2S

Molecular Weight: 405.31

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=S(=O)(NN=C(c1ccccc1)c1ccccc1)c1ccc(Cl)cc1Cl

Standard InChI:  InChI=1S/C19H14Cl2N2O2S/c20-16-11-12-18(17(21)13-16)26(24,25)23-22-19(14-7-3-1-4-8-14)15-9-5-2-6-10-15/h1-13,23H

Standard InChI Key:  QURGCACNSJIUFS-UHFFFAOYSA-N

Associated Targets(non-human)

Bacterial urease 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 405.31Molecular Weight (Monoisotopic): 404.0153AlogP: 4.72#Rotatable Bonds: 5
Polar Surface Area: 58.53Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.97CX Basic pKa: CX LogP: 5.67CX LogD: 5.63
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.49Np Likeness Score: -1.26

References

1. Arshia, Begum F, Almandil NB, Lodhi MA, Khan KM, Hameed A, Perveen S..  (2019)  Synthesis and urease inhibitory potential of benzophenone sulfonamide hybrid in vitro and in silico.,  27  (6): [PMID:30738655] [10.1016/j.bmc.2019.01.043]

Source